(Press-News.org)
Bone-destructive diseases such as osteoporosis and chronic inflammatory arthritis affect millions of people worldwide, causing pain, fractures, and decreased quality of life. These conditions often result from the dysregulation of osteoclasts—specialized cells responsible for breaking down bone tissue. Today, many promising treatments target the receptor activator of nuclear factor kappa B ligand (RANKL)-RANK-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling pathway, which controls osteoclast formation. When the protein RANKL binds to its receptor RANK on osteoclast precursor cells, it triggers a cascade of signals through an adapter molecule called TRAF6, ultimately leading to the formation of mature osteoclasts.
While effective, these therapies come with severe limitations in either potency or specificity. Because the RANKL-RANK-TRAF6 signaling pathway is involved in many vital biological processes, including immune system function and mammary gland development, drugs that broadly inhibit this pathway can cause diverse side effects. Moreover, synthetic peptides previously developed to target the RANK-TRAF6 interaction have shown limited efficacy, requiring high concentrations to achieve meaningful effects. These issues highlight the need for more targeted interventions that can tightly modulate osteoclast development without disrupting other essential cellular processes.
Against this backdrop, a research team led by Professor Kiyotaka Nishikawa from the Department of Molecular Life Sciences, Doshisha University, Japan, has developed a novel compound that could be useful for treating bone-destructive diseases. Their study, published in Communications Biology on April 22, 2025, describes a tetravalent peptide that regulates the interaction between RANK and TRAF6 by fine-tuning specific downstream signals. The research was co-authored by Dr. Masataka Anzai and Assistant Professor Miho Watanabe-Takahashi, also from Doshisha University.
First, the team used an innovative screening method to identify promising tetravalent peptide structures. This led them to WHD-tet, which binds to TRAF6 through a multivalent interaction. They then developed a cell-permeable form of this peptide, called CR4-WHD-tet, which efficiently inhibited osteoclast development in lab cultures at concentrations significantly lower than previously known compounds.
What makes this discovery particularly noteworthy is how the peptide works. Rather than completely blocking all downstream signals, it specifically inhibits the recruitment of a protein called MKK3 to TRAF6. In turn, this prevents the activation of p38-MAPK, a critical signaling molecule in late-stage osteoclast development. “The tetravalent peptide we identified here is potentially a novel type of therapeutic agent for osteoclast-related diseases with fewer side effects than conventional medications,” explains Prof. Nishikawa.
When tested in mice, CR4-WHD-tet effectively prevented bone loss in a RANKL-induced bone disease model. Notably, the peptide accumulated preferentially in bone tissue due to its acidic amino acid composition, enhancing its therapeutic potential. Additionally, it did not disrupt the function of osteoblasts—the cells responsible for building new bone—suggesting a highly targeted effect on bone resorption without compromising bone formation.
Beyond its therapeutic potential, this research has revealed important new insights into the mechanisms of osteoclastogenesis. The study demonstrated that MKK3 plays a crucial role in the late stage of osteoclast differentiation, specifically affecting the nuclear localization of p38-MAPK. This finding helps clarify the temporal dynamics of signaling pathways during osteoclast development, shedding light on the different molecular mechanisms that are at play during early versus late stages of differentiation.
Overall, this work represents a significant advancement in the treatment of bone-destructive diseases, offering hope for therapies that can effectively maintain bone density while minimizing unwanted effects on other biological systems. “Our study’s new strategic concept of fine-tuning, rather than blocking, disease-related downstream signals pave the way for the development of new types of therapeutics,” notes Prof. Nishikawa.
With any luck, further efforts in this field will lead to treatments that can significantly improve the quality of life of the millions of patients suffering from bone-destructive diseases.
About Professor Kiyotaka Nishikawa from Doshisha University, Japan
Professor Kiyotaka Nishikawa obtained Master’s and PhD degrees from The University of Tokyo in 1986 and 1989, respectively. He joined Doshisha University in 2008, where he currently serves as a full Professor. He specializes in molecular and cellular biology, covering topics such as peptide engineering, host–pathogen interactions, and intracellular trafficking. He has over 60 scientific publications to his name.
Funding information
This work was supported by grants from the Japan Society for the Promotion of Science (JSPS; KAKENHI grant number JP22J11001), the Japan Science and Technology (JST; SPRING grant number JPMJSP2129), and the Joint Research Project of the Institute of Medical Science, The University of Tokyo.
Media contact:
Organization for Research Initiatives & Development
Doshisha University
Kyotanabe, Kyoto 610-0394, JAPAN
E-mail：jt-ura@mail.doshisha.ac.jp
END
Knowing the molecule behind light sensitivity in migraines could open the door to better treatments
Scientists in the UK, Australia and China have identified a brain molecule called NEAT1 that appears to play a central role in triggering light sensitivity (photophobia), a common and debilitating symptom of migraines. Their findings, published in The Journal of Headache and Pain, highlight how this molecule affects the brain's pain response, contributing to the uncomfortable reaction to light that's common during migraines.
NEAT1 belongs to a group of molecules known as long noncoding RNAs. Unlike most RNA, which carries instructions for making ...
There is a strong association between an older person’s view of how they are ageing and how well they will physically recover after a fall.
That is the finding of a new research study from Imperial College London and Coventry University, which is the first to suggest how important psychological factors may be in post-fall physical recovery. The study is published in the Journal of the American Geriatrics Society.
Falls in older adults are a major health concern because they can lead to high levels of physical disability and hospitalisation, as well as affecting people’s ability to live independently. The consequences of falls in older ...
The Lancet: Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, finds trial
In women with dense breasts (breasts with relatively low levels of fatty tissue) and a negative mammogram, supplemental imaging techniques detect early-stage cancers, with imaging techniques three times more effective than ultrasound, finds a phase 3 randomised control trial published in The Lancet.
Women with extremely dense breasts, about 10% of those aged 50-70 years in the UK, face a fourfold increased ...
People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers.
Long-term users also tend to experience worse withdrawal symptoms, and for a longer period of time, than short-term users, and are less likely to be able to stop taking the drug when they attempt to do so, according to the findings published in Psychiatry Research.
The study’s lead author Dr Mark Horowitz, visiting clinical researcher at UCL Division of Psychiatry, said: “Our findings confirm what many researchers ...
URBANA, Ill. – Gully erosion is the most severe form of soil erosion, and it can seriously impact agricultural fields, contributing to sediment loss and nutrient runoff into waterways. Gullies can be triggered suddenly by a single heavy rainfall event, creating deep channels that are difficult to rehabilitate even with heavy machinery. Accurately predicting where gully erosion is likely to occur allows agricultural producers and land managers to target their conservation efforts more effectively.
In a new study, University of Illinois Urbana-Champaign researchers use a new AI-driven approach that combines machine learning with an interpretability ...
Researchers from the University of Missouri School of Medicine have shed light on what populations are more likely to be prescribed a high dose of opioid medication. This increases their risk of developing opioid use disorder.
Opioids like hydrocodone or oxycodone are typically prescribed to relieve intense pain. A prescription can become an addiction; side effects include building a tolerance to the medication – so the patient has to take a higher dose to feel relief – or becoming physically dependent on the drug. These ...
Irvine, Calif., May 21, 2025 — In a paper published today in Science Advances, researchers at the University of California, Irvine, Germany’s Max Planck Institute for Chemistry, Pennsylvania State University and other international institutions report that the application of personal care products such as fragrances and body lotions suppresses a potentially unhealthy “human oxidation field” that exists around our bodies.
This zone, which was the subject of a paper by the same team published in Science in 2022, is created when oils and fats on skin react with ozone, an important oxidant in the indoor environment. ...
Many grooves and dimples on the surface of the brain are unique to humans, but they're often dismissed as an uninteresting consequence of packing an unusually large brain into a too-small skull.
But neuroscientists are finding that these folds are not mere artifacts, like the puffy folds you get when forcing a sleeping bag into a stuff sack. The depths of some of the smallest of these grooves seem to be linked to increased interconnectedness in the brain and better reasoning ability.
In a study published May 19 in The Journal of Neuroscience, University of California, Berkeley, researchers show that in children and adolescents, the depths of some small grooves are correlated with ...
Rutgers University-New Brunswick researchers have discovered a new class of materials – called intercrystals – with unique electronic properties that could power future technologies.
Intercrystals exhibit newly discovered forms of electronic properties that could pave the way for advancements in more efficient electronic components, quantum computing and environmentally friendly materials, the scientists said.
As described in a report in the science journal Nature Materials, the scientists stacked two ultrathin layers of graphene, each a one-atom-thick sheet of carbon atoms arranged ...
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, MAY 21, 2025
MINNEAPOLIS — There’s good news for people with migraine who take common drugs before or during pregnancy—a new study found no increase in neurodevelopmental disorders such as autism and ADHD in their children. The study, which looked at drugs used for migraine attacks called triptans, is published on May 21, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.
The study does not prove that there is a link between these drugs and neurodevelopment disorders.
“These results are encouraging for people with migraine, who may be taking these drugs before they even ...
